Internal Medicine & Geriatrics

Postal addressShow on map
3500 Camp Bowie Blvd
76107 Fort Worth
United States
Postal addressShow on map
United States

3 Active
34 Finished

34 results

Filter

Finished

Geriatric Academic Career Award (GACA)
Camp, K.
Health Resources & Service Administratio
1/09/19 → 31/08/23
Project: Research
Collective Action to Drive Systems-Level Change
Severance, J. & Knebl, J.
United Way of Tarrant County
1/07/19 → 30/06/20
Project: Research
BN4003 l Version 2, entitled "A MULTICENTER, OPEN-LABEL, LONG-TERM EXTENSION OF PHASE ill STUDIES (BN29552/BN29553) OF CRENEZUMAB IN PATIENTS WITH ALZHEIMER'S DISEASE
Knebl, J.
Roche Diagnostics Corporation
30/11/18 → 30/11/21
Project: Research
Assessing the Utility and Effectiveness of Dementia Patient Monitoring Technology
Reuter, K. & Knebl, J.
Texas A&M Health Science Center
22/08/18 → 31/08/20
Project: Research
Collective Action to Drive Systems-Level Change
Severance, J. & Knebl, J.
United Way of Tarrant County
1/07/18 → 30/06/19
Project: Research
ALZHEIMER¿S DISEASE- DONEPEZIL HYDROCHLORIDE AND MEMANTINE HYDROCHLORIDE
Knebl, J.
Merck Co.
31/05/18 → 31/05/21
Project: Research
HRSA GWEP Small Networking Meetings
Knebl, J. & Severance, J.
American Geriatrics Society
1/09/17 → 31/12/17
Project: Research
A phase III randomised, double-blind trial to evaluate efficacy and safety of once daily empagliflozin 10 mg compared to placebo, in patients with chronic Heart Failure with reduced Ejection Fraction (HFrEF).
Kline, G.
Boehringer Ingelheim International GmbH
25/04/17 → 24/04/21
Project: Research
A phase III randomised, double-blind trial to evaluate efficacy and safety of once daily empagliflozin 10 mg compared to placebo, in patients with chronic Heart Failure with preserved Ejection Fraction (HFpEF).
Kline, G.
Boehringer Ingelheim International GmbH
25/04/17 → 24/04/21
Project: Research
PROMINENT- PEMAFIBRATE TO REDUCE CARDIOVASCULAR OUTCOMES BY REDUCING TRIGLYCERIDES IN PATIENTS WITH DIABETES
Kline, G.
Kowa Research Institute, Inc.
31/03/17 → 31/03/21
Project: Research
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Effects of Bempedoic Acid (ETC-I 002) on the Occurrence of Major Cardiovascular Events in Patients with, or at High Risk For,Cardiovascular Disease Who Are Statin Intolerant
Kline, G.
Esperion Therapeutics, Inc.
13/02/17 → 13/02/21
Project: Research
An Interprofessional Approach to Patient Safety Improvement in Skilled Nursing Facilities
Ross, S.
Intramural Research(UNTHSC)
1/01/17 → 30/06/18
Project: Research
Opportunities for Peer Models of Health Promotion in Senior Centers: An Exploratory Study
Severance, J.
Intramural Research(UNTHSC)
1/01/17 → 31/12/17
Project: Research
A Randomized, Double-Blind, Placebo-Controlled and Delayed-Start Study of LY3314814 in Mild Alzheimer's Disease Dementia (The DAYBREAK Study)
Knebl, J.
Eli Lilly
13/10/16 → 12/10/21
Project: Research
"A PHASE Ill, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF CRENEZUMAB IN PATIENTS WITH PRODROMAL TO MILD ALZHEIMER'S DISEASE"
Knebl, J.
Hoffmann-La Roche Inc.
18/08/16 → 17/08/21
Project: Research
Workforce Enhancement Healthy Aging and Independent Living (WE HAIL)
Knebl, J., Fairchild, T., Severance, J., Fulda, K., Ross, S. & Bugnariu, N.
Health Resources & Service Administratio
1/07/15 → 30/06/19
Project: Research
Opioid Supplement
Knebl, J.
Health Resources & Service Administratio
1/07/15 → 30/06/19
Project: Research
Workforce Enhancement Healthy Aging and Independent Living (WE HAIL)
Knebl, J. & Ross, S.
Health Resources & Service Administratio
1/07/15 → 30/06/19
Project: Research
An open-label extension study to evaluate the long-term safety and tolerability of Lu AE58054 as adjunctive treatment to donepezil in patients with mild-moderate Alzheimer¿s disease
Knebl, J.
Lundbeck Pharmaceuticals
3/04/15 → 30/04/20
Project: Research
A Phase 3 Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy, Long-term Safety and Tolerability of PF-04950615 in Subjects with Primary Hyperlipidemia or Mixed Dyslipdemia at Risk of Cardiovascular Events
Kline, G.
Pfizer, Inc.
17/03/15 → 31/03/20
Project: Research
Randomized, Double-blind, Parallel Group, Placebo-controlled, Fixed-dose of Lu AE58054 In Patients with Mild - Moderate Alzheimer's Disease Treated with Donepazil; Study 2
Knebl, J.
Lundbeck Pharmaceuticals
8/12/14 → 31/12/19
Project: Research
A Phase II, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study to Investigate the Efficacy and Safety of RO4602522 Added to Background Alzheimer¿s Disease Therapy in Patients with Moderate Severity Alzheimer¿s Disease
Knebl, J.
Hoffmann-La Roche Inc.
25/10/13 → 31/03/19
Project: Research
Tuberculosis Trials Consortium
Weis, S.
Centers for Disease Control
18/09/13 → 17/09/14
Project: Research
Discharge Planning and Care Coordinated with Medicaid Eligible Elders with TCOM Student Danielle Ortega
Knebl, J.
Intramural Research(UNTHSC)
1/09/13 → 31/08/14
Project: Research
Reynolds Interprofessional Geriatrics Education and Training in Texas (/GET-IT) Program
Knebl, J.
Donald W. Reynolds Foundation
1/07/13 → 30/06/17
Project: Research
Discharge Planning and Care Coordination for Medicaid Eligible Elders
Knebl, J., Bugnariu, N. & O'Bryant, S.
Centers for Medicare & Medicaid Services
1/06/13 → 31/12/17
Project: Research
A Readomized. Double-blind, Placebo-controlled,Parallel-group Studfy to Evaluate the Effect of SAR236553/REGN727 on the Occurrence of Cardiovascular Events in Patgients Who Have Recently Experienced an Acute Coronary Syndrome
Kline, G.
Sanofi Pasteur, Inc.
31/01/13 → 30/01/20
Project: Research
Tuberculosis Trials Consortium
Weis, S.
Centers for Disease Control
18/09/12 → 17/09/13
Project: Research
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel-Group Efficacy and Safety Trial of Bapineuzumab (AAB-001, ELN115727) in Subjects with Mild to Moderate Alzheimer Disease Who Are Apolipoprotein E ¿4 Non-Carriers
Knebl, J.
Pfizer, Inc.
14/11/11 → 30/11/15
Project: Research
The Texas Consortium Geriatrics Education Center
Knebl, J.
Baylor College of Medicine
1/07/10 → 30/06/15
Project: Research
A Phase 3 Extension, Multicenter, Double-Blind, Long Term Safety and Tolerability Treatment Trial of Bapineuzumab (ABB-001, ELN115727) in Subjects with Alzheimer's Disease who Participated in Study ELN115727-301 or in Study ELN115727-302
Knebl, J.
Janssen Pharmaceuticals
4/05/10 → 31/12/13
Project: Research
Tuberculosis Trials Consortium
Weis, S.
Centers for Disease Control
18/09/09 → 17/09/19
Project: Research
Task Order #30 Quantifying The Risk Of Premature Death In TB Survivors
Weis, S. & Miller, T.
Centers for Disease Control
15/09/09 → 14/09/11
Project: Research
Task Order # 32 Quantifying The Risk Of Premature Death in TB Survivors
Weis, S. & Miller, T.
Centers for Disease Control
15/09/09 → 14/09/11
Project: Research